Chemoinformaics analysis of 4-O-METHYL-D-GLUCURONIC-ACID
| Molecular Weight | 214.305 | nRot | 10 |
| Heavy Atom Molecular Weight | 192.129 | nRig | 2 |
| Exact Molecular Weight | 214.157 | nRing | 0 |
| Solubility: LogS | -2.074 | nHRing | 0 |
| Solubility: LogP | 2.659 | No. of Aliphatic Rings | 0 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 37 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 15 | No. of Aromatic Carbocycles | 0 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 22 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 12 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 37.1154 |
| nHD | 1 | BPOL | 23.8066 |
| QED | 0.568 |
| Synth | 1.861 |
| Natural Product Likeliness | 0.778 |
| NR-PPAR-gamma | 0.967 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.772 |
| Pgp-sub | 0.002 |
| HIA | 0.009 |
| CACO-2 | -4.923 |
| MDCK | 0.0000272 |
| BBB | 0.626 |
| PPB | 0.88417 |
| VDSS | 0.264 |
| FU | 0.0885352 |
| CYP1A2-inh | 0.039 |
| CYP1A2-sub | 0.483 |
| CYP2c19-inh | 0.02 |
| CYP2c19-sub | 0.134 |
| CYP2c9-inh | 0.05 |
| CYP2c9-sub | 0.974 |
| CYP2d6-inh | 0.008 |
| CYP2d6-sub | 0.237 |
| CYP3a4-inh | 0.008 |
| CYP3a4-sub | 0.031 |
| CL | 4.773 |
| T12 | 0.856 |
| hERG | 0.013 |
| Ames | 0.034 |
| ROA | 0.022 |
| SkinSen | 0.105 |
| Carcinogencity | 0.083 |
| EI | 0.964 |
| Respiratory | 0.175 |
| NR-Aromatase | 0.013 |
| Antiviral | Yes |
| Prediction | 0.627273 |